glp 1 class of drugs A schematic overview GLP-1 receptor agonists: classification, drug Glucagon-like peptide-1 receptor agonists(GLP-1RAs)** GLP-1
Description
They estimate companies are currently charging an average of $7,000 for obesity drugs, but that will likely decline to under $3,000 by 2031
The drug, manufactured by Novo Nordisk, is approved for the treatment of Type 2 diabetes but has been increasingly used for weight loss
What do you think are the reason
With respect to GLP-1RAs, liraglutide and semaglutide have demonstrated a reduction in the risk of major adverse cardiovascular events (MACE) [16, 17], and, while yet not published, early reports for dulaglutide indicate CV benefits in patients with a wide range of CV risk [18]
